| Health / Medical Topics |
Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine
A vaccine formulation consisting of several types of human papillomavirus (HPV)-derived noninfectious virus-like particles (VLPs) with potential immunoprophylactic activity. Upon administration, HPV L1 VLP vaccine V504 may generate humoral immunity against various HPV L1 major capsid proteins, thereby preventing cervical infection upon exposure to the associated HPV types. VLPs are composed of self-assembling L1 major capsid proteins or functional L1 major capsid protein derivatives. (NCI Thesaurus)
YOU MAY ALSO LIKE
The process of manufacturing non-prescription medications for humans by a pharmaceutical company.
The process of distributing non-prescription medications for human use.
Early-to late-stage myeloid progenitor cells derived from adult human stem cells with potential hematopoietic activity. Upon infusion, human myeloid progenitor cells CLT-008…
A human monoclonal antibody (B11) directed against the mannose receptor and linked to the beta-subunit of human chorionic gonadotropin (hCG beta) with…
A naturally-occurring human IgM monoclonal antibody with potential antineoplastic activity. Human monoclonal antibody 216, derived from the gene VH4-34, binds to the…
A human monoclonal immunoglobulin M (IgM) antibody with potential antineoplastic activity. Human MOAB LICO 28a32 binds to the colon tumor-associated antigen…
